Skip to main content

ZURICH HEART HOUSE

The Zurich Heart House creates and communicates new knowledge in the field of cardiovascular diseases and supports through its affiliation with the Center for Molecular Cardiology of the University of Zurich and as the seat of the "Foundation for Cardiovascular Research", it is one of the most impactful cardiology research and education centres in Europe. Its reach goes far beyond its home and thanks to its close collaboration with the London Heart House involves activities in the United Kingdom, Germany, Easter countries such as Azerbaijan, Georgia, North Macedonia and Mexico.

Thanks to its global reach, the Zurich Heart House is a place of creative knowledge exchange between researchers, scientists, clinicians, practicing physicians, lecturers and staff. As a think tank, it is intended to strengthen Zurich as a location and serve as a service centre for doctors and patients with cardiovascular diseases.

Stay up to date with all our events - subscribe to our Newsletter HERE!


PCHF London Online 3rd Edition - Brand NEW Modules are now available!!!
Check them out here: www.pchfonline.uk

Enjoy discounted pricing with our bundles!

If you would like to purchase a combination of modules that is not available as a bundle, please contact us, and we will be happy to offer you a customized discounted option.

BCS and BSH members get a 10% discount! To get the discount please send us an e-mail at pchfonline@zhh.ch

Do not miss this opportunity: learn from the best, stay up to date with the latest developments in Heart Failure and in your own pace and convenience.

Start learning NOW!


Annual Report 2024*

*in German

ZHH News

TFL-YouTube

InsideCardiology: New Hot Topics in Cardiology Video!

Check out the new video on "Betablockers in CV Medicine: Towards Precision Medicine" with Professor Thomas F. Lüscher.

Watch the video and subscribe to InsideCardiology here!

Florian A. Wenzl

Dr. Florian A. Wenzl receives the prestigious Albrecht von Haller Young Investigator Award from the Swiss Heart Foundation

Dr. Florian A. Wenzl was honoured with the award for his work addressing residual cardiovascular risk following acute coronary syndromes (ACS).

Congratulations!

Read the press announcement here!

PCHF3rdEdition

PCHF London Online 3rd Edition - Brand NEW Modules are now available!!!

We have great news: New online courses are now available on our E-learning platform.
Check them out here: www.pchfonline.uk

Cardiology News

Betablockers

Rethinking beta-blocker therapy after heart attacks: time for personalized secondary prevention

Since the Beta-Blocker Heart Attack Trial in 1982, beta-blockers have been a cornerstone of therapy after myocardial infarction. Advances in the management of myocardial infarction in the past decades have prompted a reevaluation of early trials across the spectrum of left ventricular ejection fraction (LVEF).

Read full article (N ENGL J MED 394;6) here!

AI Tools

New AI tool improves treatment of cancer patients after heart attack

A recent study by Dr. Florian A. Wenzl and colleagues, published in The Lancet, applied artificial intelligence (AI) to population-representative data to develop a cancer-specific risk prediction tool: ONCO-ACS. The model predicts mortality, major bleeding, and ischaemic events – helping clinicians balance treatment benefits and risks.

Read full article (Lancet 2026; 407: 515–28) here!

Nicotine

Nicotine and the cardiovascular system: unmasking a global public health threat

Nicotine-containing products, whether combustible or smokeless, pose a growing threat to cardiovascular (CV) health. While tobacco smoking continues to cause millions of deaths annually, the rapid uptake of e-cigarettes, heated tobacco, and synthetic nicotine pouches,..., risks reversing decades of progress in tobacco control. 

Read full article (European Heart Journal (2025) 00, 1–18) here!